This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Osaka University, Bikenbiomics Co., Ltd.. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020-2026
Title: The Innovations of Takahiro Maruno
Introduction
Takahiro Maruno is a notable inventor based in Suita, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of peptides that inhibit the colonization of pathogenic bacteria in digestive organs. His work is crucial in addressing health issues related to bacterial infections.
Latest Patents
One of Takahiro Maruno's key patents is titled "Peptide inhibiting colonization by pathogenic bacteria, and colonization inhibitor including same." This patent describes a peptide capable of preventing pathogenic bacteria from colonizing in digestive organs. The peptide comprises a first domain with an amino acid sequence that binds to a minor pilin of IVb fimbriae, and a second domain that allows for multimerization. The second domain is connected to the first domain via a linker sequence. This innovative approach has the potential to improve health outcomes by targeting harmful bacteria.
Career Highlights
Throughout his career, Takahiro Maruno has worked with reputable organizations such as Bikenbiomics Co., Ltd. and Osaka University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Daisuke Motooka and Shota Nakamura. Their collaborative efforts have further advanced the research and development of innovative solutions in biotechnology.
Conclusion
Takahiro Maruno's contributions to the field of biotechnology, particularly through his patent on peptides that inhibit pathogenic bacteria, highlight his role as an influential inventor. His work continues to pave the way for advancements in health and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile